Tyme Technologies Inc

NASDAQ:TYME   11:12:28 AM EDT
0.33
-0.03 (-8.51%)
Products, Regulatory

Tyme Technologies, Inc. Announces Additional Encouraging Preclinical Data On Tyme-19 In Sars Cov-2 Infections

Published: 12/14/2021 12:39 GMT
Tyme Technologies Inc (TYME) - Tyme Technologies, Inc. Announces Additional Encouraging Preclinical Data on the Effect of Tyme-19 in Sars Cov-2 Infections.
Tyme Technologies Inc - Tyme-19 Demonstrated an Antiviral Effect Against Sars Cov-2 in Human Lung Epithelial Cells.
Tyme Technologies Inc - Plans to Advance Toward an Ind for Tyme-19 in Covid-19.
Tyme Technologies Inc - Completed Toxicity Studies With Tyme-19 Expected to Enable an Ind Application and Support a Forthcoming Clinical Trial.